Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive A Prestidge

Showing results (181-190 of 221) with videos related to

Pageof 23
Sort By:
Antimicrobial Agents and Chemotherapy|April 12, 2017
A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm ActivityKatharina Richter, Nicky Thomas, Jolien Claeys, et al.
Molecular Pharmaceutics|March 3, 2022
Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and <i>In Vivo</i> Oral AbsorptionRuba Almasri, Hayley B Schultz, Amalie Møller, et al.
International Journal of Pharmaceutics|June 2, 2019
Enzyme responsive copolymer micelles enhance the anti-biofilm efficacy of the antiseptic chlorhexidineYassamin N Albayaty, Nicky Thomas, Manasi Jambhrunkar, et al.
Advanced Drug Delivery Reviews|December 12, 2018
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challengesPaul Joyce, Tahnee J Dening, Tahlia R Meola, et al.
Journal of Pharmaceutical Sciences|September 26, 2020
A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein TherapeuticsLeah Wright, Paul Joyce, Timothy J Barnes, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 18, 2012
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibioticsJohn Gar Yan Chan, Hak-Kim Chan, Clive A Prestidge, et al.
Egastroenterology|February 13, 2025
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidenceAmin Ariaee, Sabrina Koentgen, Hannah R Wardill, et al.
Pharmaceutics|February 24, 2024
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or VenetoclaxThao M Nguyen, Paul Joyce, David M Ross, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 12, 2021
Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa BiofilmsChelsea R Thorn, Cristiane de Souza Carvalho-Wodarz, Justus C Horstmann, et al.
Molecular Pharmaceutics|November 3, 2015
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak BasesShasha Rao, Katharina Richter, Tri-Hung Nguyen, et al.
Pageof 23

Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|April 12, 2017
A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm ActivityKatharina Richter, Nicky Thomas, Jolien Claeys, et al.
Molecular Pharmaceutics|March 3, 2022
Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and <i>In Vivo</i> Oral AbsorptionRuba Almasri, Hayley B Schultz, Amalie Møller, et al.
International Journal of Pharmaceutics|June 2, 2019
Enzyme responsive copolymer micelles enhance the anti-biofilm efficacy of the antiseptic chlorhexidineYassamin N Albayaty, Nicky Thomas, Manasi Jambhrunkar, et al.
Advanced Drug Delivery Reviews|December 12, 2018
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challengesPaul Joyce, Tahnee J Dening, Tahlia R Meola, et al.
Journal of Pharmaceutical Sciences|September 26, 2020
A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein TherapeuticsLeah Wright, Paul Joyce, Timothy J Barnes, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 18, 2012
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibioticsJohn Gar Yan Chan, Hak-Kim Chan, Clive A Prestidge, et al.
Egastroenterology|February 13, 2025
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidenceAmin Ariaee, Sabrina Koentgen, Hannah R Wardill, et al.
Pharmaceutics|February 24, 2024
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or VenetoclaxThao M Nguyen, Paul Joyce, David M Ross, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 12, 2021
Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa BiofilmsChelsea R Thorn, Cristiane de Souza Carvalho-Wodarz, Justus C Horstmann, et al.
Molecular Pharmaceutics|November 3, 2015
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak BasesShasha Rao, Katharina Richter, Tri-Hung Nguyen, et al.
Pageof 23